Guardian Pharmacy Services revenue was $1.46B for the trailing 12 months ending Jun 30, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q2 2026) ending on Jun 30, 2026 was $351.8M, up 4.5% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, GRDN annual revenue was $1.4B, with 17.9% growth year-over-year.
GRDN past revenue growth
How has GRDN's revenue growth performed historically?
On Aug 6, 2026, Guardian Pharmacy Services (NYSE: GRDN) reported Q2 2026 revenue of $351.77 million up 2.16% year over year. In the same quarter last year, Guardian Pharmacy Services's revenue was $344.33 million.
What was Guardian Pharmacy Services's revenue in 2025?
Guardian Pharmacy Services's annual revenue for the twelve months ending Dec 31, 2025 was $1.45 billion, a 17.93% increase year over year.
How much does Guardian Pharmacy Services make in a day?
Based on Guardian Pharmacy Services annual revenue for the past three years, GRDN makes an average of $3,400,262.10 per day.
What was Guardian Pharmacy Services's annual revenue growth in the past year?
As of Q3 2026, Guardian Pharmacy Services's revenue has grown 10.31% year over year. This is 1.16 percentage points higher than the US Medical Care Facilities industry revenue growth rate of 9.15%. Guardian Pharmacy Services's revenue in the past year totaled $1.46 billion.
How much does Guardian Pharmacy Services make in a year?
Guardian Pharmacy Services's revenue by year for the past three years is:
Guardian Pharmacy Services's revenue for the twelve months ending Dec 31, 2025 was $1.45 billion, a 17.93% increase year over year.
Guardian Pharmacy Services's annual revenue for Dec 31, 2024 was $1.23 billion, a 17.42% increase from 2023.
Guardian Pharmacy Services's annual revenue for 2023 was $1.05 billion, a 15.1% increase from 2022.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.